Bioprocess leadership CPC leads in single-use connection technologies for bioprocessing, sterile connect and sterile disconnect, offering products that integrate with bioreactors, process containers, tubing manifolds and transfer lines—a strong opportunity to upsell to biopharma, cell therapy and gene therapy customers seeking scalable sterile solutions.

Medical safety appeal The company’s connectors enhance patient safety by preventing misconnections and enabling safer, easier fluid handling across medical devices such as surgical equipment, dialysis and diagnostics—prospects include medical device manufacturers and OEMs focusing on safety-critical fluid pathways.

Aseptic innovation Continuous product introductions like aseptic CPC connectors, MicroCNX series and W Series demonstrate a commitment to sterile processing at various scales—targetable opportunities with biopharma contract manufacturers, CROs and hospitalsmodernizing sterile workflows.

Diversified applications CPC serves multiple end markets from biopharma to analytical instrumentation, chemical management and consumer electronics, presenting cross-selling potential to customers expanding into new applications such as chemical dispensing, ink management or fluid handling systems.

Growth through events Active participation in industry events (Compamed, Interphex) and a recent product launch cadence indicate vibrant market engagement—sales teams should capitalize on event leads and showcase portfolio breadth to convert interest into multi-product contracts.